Titre : Cellules spumeuses

Cellules spumeuses : Questions médicales fréquentes

Termes MeSH sélectionnés :

Learning Disabilities
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Cellules spumeuses : Questions médicales les plus fréquentes", "headline": "Cellules spumeuses : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Cellules spumeuses : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-24", "dateModified": "2025-04-18", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Cellules spumeuses" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Macrophages", "url": "https://questionsmedicales.fr/mesh/D008264", "about": { "@type": "MedicalCondition", "name": "Macrophages", "code": { "@type": "MedicalCode", "code": "D008264", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.680.397" } } }, "about": { "@type": "MedicalCondition", "name": "Cellules spumeuses", "alternateName": "Foam Cells", "code": { "@type": "MedicalCode", "code": "D005487", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Maria Kurańska", "url": "https://questionsmedicales.fr/author/Maria%20Kura%C5%84ska", "affiliation": { "@type": "Organization", "name": "Department of Chemistry and Technology of Polymers, Faculty of Chemical Engineering and Technology, Cracow University of Technology, Warszawska 24, 31-155 Cracow, Poland." } }, { "@type": "Person", "name": "Aleksander Prociak", "url": "https://questionsmedicales.fr/author/Aleksander%20Prociak", "affiliation": { "@type": "Organization", "name": "Department of Chemistry and Technology of Polymers, Faculty of Chemical Engineering and Technology, Cracow University of Technology, Warszawska 24, 31-155 Cracow, Poland." } }, { "@type": "Person", "name": "Aniket Raje", "url": "https://questionsmedicales.fr/author/Aniket%20Raje", "affiliation": { "@type": "Organization", "name": "Institute of Membrane Research, Helmholtz-Zentrum Hereon, Max-Planck-Strasse 1, 21502 Geesthacht, Germany." } }, { "@type": "Person", "name": "Joachim Koll", "url": "https://questionsmedicales.fr/author/Joachim%20Koll", "affiliation": { "@type": "Organization", "name": "Institute of Membrane Research, Helmholtz-Zentrum Hereon, Max-Planck-Strasse 1, 21502 Geesthacht, Germany." } }, { "@type": "Person", "name": "Jelena Lillepärg", "url": "https://questionsmedicales.fr/author/Jelena%20Lillep%C3%A4rg", "affiliation": { "@type": "Organization", "name": "Institute of Membrane Research, Helmholtz-Zentrum Hereon, Max-Planck-Strasse 1, 21502 Geesthacht, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "How Do Intermediate Grade Students With and Without Language-Based Learning Disabilities Use Noun Phrases in Narrative Writing?", "datePublished": "2023-06-20", "url": "https://questionsmedicales.fr/article/37338979", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1044/2023_AJSLP-22-00331" } }, { "@type": "ScholarlyArticle", "name": "Improving access to primary care and annual health checks for people who have a learning disability: a multistakeholder qualitative study.", "datePublished": "2022-12-23", "url": "https://questionsmedicales.fr/article/36564116", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bmjopen-2022-065945" } }, { "@type": "ScholarlyArticle", "name": "Evaluating the nutrition and body mass index clinical link pathway in mental health and learning disability services: A mixed-methods study.", "datePublished": "2024-06-13", "url": "https://questionsmedicales.fr/article/38870198", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0303893" } }, { "@type": "ScholarlyArticle", "name": "Maternal smoking cessation in the first trimester still poses an increased risk of attention-deficit/hyperactivity disorder and learning disability in offspring.", "datePublished": "2024-07-16", "url": "https://questionsmedicales.fr/article/39081356", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpubh.2024.1386137" } }, { "@type": "ScholarlyArticle", "name": "A protocol to identify the barriers and facilitators for people with severe mental illness and/or learning disabilities for PErson Centred Cancer Screening Services (PECCS).", "datePublished": "2022-11-30", "url": "https://questionsmedicales.fr/article/36449513", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0278238" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Systèmes sanguin et immunitaire", "item": "https://questionsmedicales.fr/mesh/D006424" }, { "@type": "ListItem", "position": 3, "name": "Système immunitaire", "item": "https://questionsmedicales.fr/mesh/D007107" }, { "@type": "ListItem", "position": 4, "name": "Phagocytes", "item": "https://questionsmedicales.fr/mesh/D010586" }, { "@type": "ListItem", "position": 5, "name": "Macrophages", "item": "https://questionsmedicales.fr/mesh/D008264" }, { "@type": "ListItem", "position": 6, "name": "Cellules spumeuses", "item": "https://questionsmedicales.fr/mesh/D005487" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Cellules spumeuses - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Cellules spumeuses", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Cellules spumeuses", "description": "Comment diagnostique-t-on les cellules spumeuses ?\nQuels tests sont utilisés pour détecter les cellules spumeuses ?\nLes cellules spumeuses sont-elles visibles à l'échographie ?\nQuel rôle joue la biopsie dans le diagnostic ?\nPeut-on détecter les cellules spumeuses par analyse sanguine ?", "url": "https://questionsmedicales.fr/mesh/D005487?mesh_terms=Learning+Disabilities&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Cellules spumeuses", "description": "Quels symptômes sont associés aux cellules spumeuses ?\nLes cellules spumeuses causent-elles des douleurs ?\nComment les cellules spumeuses affectent-elles la circulation ?\nY a-t-il des signes cliniques visibles ?\nLes cellules spumeuses sont-elles liées à des maladies spécifiques ?", "url": "https://questionsmedicales.fr/mesh/D005487?mesh_terms=Learning+Disabilities&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Cellules spumeuses", "description": "Comment prévenir la formation de cellules spumeuses ?\nLe tabagisme influence-t-il les cellules spumeuses ?\nLe stress a-t-il un impact sur les cellules spumeuses ?\nUne alimentation riche en graisses est-elle risquée ?\nL'exercice régulier aide-t-il à prévenir les cellules spumeuses ?", "url": "https://questionsmedicales.fr/mesh/D005487?mesh_terms=Learning+Disabilities&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Cellules spumeuses", "description": "Quels traitements ciblent les cellules spumeuses ?\nLes statines aident-elles contre les cellules spumeuses ?\nY a-t-il des traitements non médicamenteux ?\nLes interventions chirurgicales sont-elles nécessaires ?\nLes traitements naturels sont-ils efficaces ?", "url": "https://questionsmedicales.fr/mesh/D005487?mesh_terms=Learning+Disabilities&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Cellules spumeuses", "description": "Quelles complications sont liées aux cellules spumeuses ?\nLes cellules spumeuses augmentent-elles le risque d'AVC ?\nPeuvent-elles causer des douleurs thoraciques ?\nLes cellules spumeuses sont-elles réversibles ?\nY a-t-il des risques de rupture de plaque ?", "url": "https://questionsmedicales.fr/mesh/D005487?mesh_terms=Learning+Disabilities&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Cellules spumeuses", "description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il la formation de cellules spumeuses ?\nLe cholestérol élevé est-il un facteur de risque ?\nLe diabète affecte-t-il la santé vasculaire ?\nLe manque d'exercice est-il un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D005487?mesh_terms=Learning+Disabilities&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on les cellules spumeuses ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'analyse histologique des tissus vasculaires." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter les cellules spumeuses ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des biopsies et des examens d'imagerie comme l'IRM peuvent être utilisés." } }, { "@type": "Question", "name": "Les cellules spumeuses sont-elles visibles à l'échographie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Elles ne sont généralement pas visibles à l'échographie standard." } }, { "@type": "Question", "name": "Quel rôle joue la biopsie dans le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "La biopsie permet d'observer la présence de cellules spumeuses dans les plaques." } }, { "@type": "Question", "name": "Peut-on détecter les cellules spumeuses par analyse sanguine ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Non, elles sont principalement détectées dans les tissus, pas dans le sang." } }, { "@type": "Question", "name": "Quels symptômes sont associés aux cellules spumeuses ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les cellules spumeuses elles-mêmes ne provoquent pas de symptômes directs." } }, { "@type": "Question", "name": "Les cellules spumeuses causent-elles des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elles ne causent pas de douleurs, mais contribuent à des maladies cardiovasculaires." } }, { "@type": "Question", "name": "Comment les cellules spumeuses affectent-elles la circulation ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent obstruer les vaisseaux sanguins, entraînant des problèmes circulatoires." } }, { "@type": "Question", "name": "Y a-t-il des signes cliniques visibles ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Non, les cellules spumeuses ne présentent pas de signes cliniques visibles." } }, { "@type": "Question", "name": "Les cellules spumeuses sont-elles liées à des maladies spécifiques ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont souvent associées à l'athérosclérose et aux maladies cardiaques." } }, { "@type": "Question", "name": "Comment prévenir la formation de cellules spumeuses ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir un mode de vie sain avec une alimentation équilibrée et de l'exercice." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il les cellules spumeuses ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme augmente le risque de formation de cellules spumeuses et d'athérosclérose." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur les cellules spumeuses ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Le stress chronique peut contribuer à des maladies cardiovasculaires, y compris les cellules spumeuses." } }, { "@type": "Question", "name": "Une alimentation riche en graisses est-elle risquée ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en graisses saturées favorise la formation de cellules spumeuses." } }, { "@type": "Question", "name": "L'exercice régulier aide-t-il à prévenir les cellules spumeuses ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier améliore la santé cardiovasculaire et réduit les risques." } }, { "@type": "Question", "name": "Quels traitements ciblent les cellules spumeuses ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements visent à réduire le cholestérol et à prévenir l'athérosclérose." } }, { "@type": "Question", "name": "Les statines aident-elles contre les cellules spumeuses ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les statines réduisent le cholestérol et limitent la formation de cellules spumeuses." } }, { "@type": "Question", "name": "Y a-t-il des traitements non médicamenteux ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation saine et l'exercice physique peuvent aider à prévenir leur formation." } }, { "@type": "Question", "name": "Les interventions chirurgicales sont-elles nécessaires ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent être nécessaires en cas de complications graves, comme une occlusion." } }, { "@type": "Question", "name": "Les traitements naturels sont-ils efficaces ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Certains compléments peuvent aider, mais leur efficacité n'est pas prouvée scientifiquement." } }, { "@type": "Question", "name": "Quelles complications sont liées aux cellules spumeuses ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent entraîner des maladies cardiovasculaires graves, comme l'infarctus." } }, { "@type": "Question", "name": "Les cellules spumeuses augmentent-elles le risque d'AVC ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent contribuer à l'athérosclérose, augmentant le risque d'AVC." } }, { "@type": "Question", "name": "Peuvent-elles causer des douleurs thoraciques ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Indirectement, en provoquant des maladies cardiaques qui peuvent entraîner des douleurs." } }, { "@type": "Question", "name": "Les cellules spumeuses sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Une fois formées, elles ne sont pas réversibles, mais leur progression peut être contrôlée." } }, { "@type": "Question", "name": "Y a-t-il des risques de rupture de plaque ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les cellules spumeuses peuvent contribuer à la rupture de plaques athéroscléreuses." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent le tabagisme, l'hypertension, le diabète et l'obésité." } }, { "@type": "Question", "name": "L'âge influence-t-il la formation de cellules spumeuses ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque augmente avec l'âge en raison de l'accumulation de lipides." } }, { "@type": "Question", "name": "Le cholestérol élevé est-il un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un taux de cholestérol élevé favorise la formation de cellules spumeuses." } }, { "@type": "Question", "name": "Le diabète affecte-t-il la santé vasculaire ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le diabète augmente le risque de maladies cardiovasculaires et de cellules spumeuses." } }, { "@type": "Question", "name": "Le manque d'exercice est-il un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire augmente le risque de formation de cellules spumeuses." } } ] } ] }

Sources (10000 au total)

How Do Intermediate Grade Students With and Without Language-Based Learning Disabilities Use Noun Phrases in Narrative Writing?

Noun phrase usage and elaboration is an important feature of literate language. In this study, we described noun phrase usage and elaboration in the narrative writing samples of intermediate grade stu... Narrative writing samples from 64 students in fourth through sixth grades were coded for five types of noun phrases using coding procedures adapted from prior research. Noun phrase ratios (NPR) were c... Students in this study included all five types of noun phrases in their narrative writing to varying degrees. Between-group differences were observed in the frequency of complex noun phrase usage. Sig... Noun phrase usage is an important consideration for both theoretical and clinical purposes. Findings from this study are related to theoretical models of writing and levels of language frameworks. The...

Improving access to primary care and annual health checks for people who have a learning disability: a multistakeholder qualitative study.

To investigate key stakeholders' views on how to improve access to primary care in general practice settings for people with learning disabilities (or intellectual disabilities). Further to explore ho... A qualitative study design was used with data collected during focus groups, interviews and open-response surveys; data analysis was thematic and informed by stakeholder consultation. Processes to fac... UK regional services including learning disability organisations, primary care general practitioner (GP) clinical practice networks and supported housing organisations.... Sixteen people participated in the study: four people with learning disabilities participated in a focus group; four relatives completed an interview or survey; eight GPs, practice nurses and supporte... Five overarching themes describing approaches to improve primary care access for people with learning disabilities were identified including: prioritisation, proactivity, innovation and improvement, p... All stakeholders identified problems, with primary care interfaces being misaligned with the needs of people with learning disabilities. The recommendations informed by all stakeholders can be used to...

Maternal smoking cessation in the first trimester still poses an increased risk of attention-deficit/hyperactivity disorder and learning disability in offspring.

Studies have found maternal smoking during pregnancy was linked to attention-deficit/hyperactivity disorder (ADHD) risk. It is unclear if maternal smoking cessation during pregnancy lowers ADHD and le... Data from the National Health and Nutrition Examination Survey 1999-2004 (8,068 participants) were used. Logistic regression was used to analyze the associations between maternal smoking and smoking c... Compared to non-smokers' offspring, maternal smoking during pregnancy increased the risk of ADHD (odds ratios [OR] = 2.07, 95% confidence interval [CI]: 1.67-2.56) and LD (OR = 1.93, 95% CI: 1.61-2.31... Maternal smoking cessation in the first trimester still poses an increased risk of ADHD and LD in offspring. Furthermore, it seems that the later the mothers quit smoking during pregnancy, the higher ...

A protocol to identify the barriers and facilitators for people with severe mental illness and/or learning disabilities for PErson Centred Cancer Screening Services (PECCS).

To identify the barriers and facilitators that people with severe mental illness and people with learning disabilities may encounter when accessing cancer screening and make recommendations for implem... An 18-month sequential, mixed-methods study comprising of two phases of work and underpinned by Normalisation Process Theory, recruiting from across the North-East and North Cumbria. The first phase a... This study has received Teesside University ethical approval, Health Research Authority approval (IRAS: 310622) and favourable opinion (REF: 22/PR/0793). Findings will be disseminated through a range ...

'Why are we stuck in hospital?' Understanding delayed hospital discharges for people with learning disabilities and/or autistic people in long-stay hospitals in the UK.

Despite longstanding efforts at de-institutionalisation, around 2000 people with learning disabilities and/or autistic people in England currently live in hospital settings, amidst reports of protract...

Joint effect of docosahexaenoic acid intake and tobacco smoke exposure on learning disability in children and adolescents: a cross-sectional study from the NHANES database.

Docosahexaenoic acid (DHA) has been reported to be associated with the children's neurodevelopment, who may be exposed to tobacco smoke simultaneously. The evidence about joint effect of DHA intake an... A cross-sectional analysis of the NHANES 1999-2004 was performed. Children and adolescents aged 6-15 years old were included. The outcome was diagnosed by parental report of ever health professionals ... We identified 5,247 children and adolescents in present study, of whom 593 (11.30%) had LD. After adjusting covariates, we observed children and adolescents with DHA intake (OR = 0.76, 95%CI: 0.61-0.9... Increasing the DHA intake and reducing tobacco smoke exposure may have a potential role in the prevention of LD in children and adolescents. This joint effect warrants further investigation by large-s...

Incidence and risk of attention-deficit/hyperactivity disorder and learning disability by adulthood after traumatic brain injury in childhood: a population-based birth cohort study.

The aim of this study was to understand the risk of developing attention-deficit/hyperactivity disorder (ADHD) or learning disability (LD) after childhood traumatic brain injury (TBI) in a population-...

Mother and Daughter with Short Stature, Microcephaly, Mild Dysmorphic Features, and Learning Disabilities Due to Ververi-Brady Syndrome Associated with a New Variant of the QRICH1 Gene.

BACKGROUND Ververi-Brady syndrome (VEBRAS) is an autosomal dominant condition associated with short stature, microcephaly, mild dysmorphic features, and learning disabilities. It was first described i...

Hospital admissions of school-age children with an intellectual disability: A population-based survey.

To describe the profiles of hospital admissions of school-age children identified with a learning disability (ICD-11 intellectual developmental disorder) and/or safeguarding needs compared to children... Data were collected about the reasons for and duration of hospital admissions of school-age children living in the study catchment area between April 2017 and March 2019; the presence (or absence) of ... Of 46 295 children in the local population, 1171 (2.53%) had a learning disability flag. The admissions of 4057 children were analysed (1956 females; age range 5-16 years, mean 10 years 6 months, SD 3... Children with learning disabilities and/or safeguarding needs have higher rates of hospital admissions than children without. Robust identification of learning disabilities in childhood is required to... Children with learning disabilities must be consistently identified in populations so that their needs are made visible. Information about these needs must be collected from educational, health, and s...